Home/Filings/4/0001493152-20-012577
4//SEC Filing

RUGG TERENCE ANTHONY 4

Accession 0001493152-20-012577

CIK 0001106838other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 6:25 PM ET

Size

5.1 KB

Accession

0001493152-20-012577

Insider Transaction Report

Form 4
Period: 2020-07-02
RUGG TERENCE ANTHONY
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2020-07-02+21,31421,314 total
Footnotes (1)
  • [F1]On July 2, 2020, the Reporting Person was granted 21,314 restricted stock units, which will be settled in shares of common stock, par value $0.000. The restricted stock units vest as to 50% of the restricted stock units on April 2, 2021 and 50% of the restricted stock units on April 2, 2022.

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001372007

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:25 PM ET
Size
5.1 KB